drugset / Trial / NCT01205529

ST-segment Elevation as an AF Endophenotype

NCT01205529

NaSingle-groupOpen-labelDiagnostic

Summary

The purpose of this study is to look for a similarity in people's genes that may help understand which people could benefit from certain drugs for the treatment of atrial fibrillation (AF).

Timeline

Start
2010-11
Primary completion
2015-06
Completion
2015-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Procainamide Small molecule 10 mg/kg Intravenous

Indications